Selecting Medical Plastic with ISO 10993: A Risk-Based Guide
Answer in one sentence: ISO 10993 material selection begins with the final device’s contact, duration, processing, sterilization, and risk assessment—not a medical-grade label alone.
Engineering scope: This guide separates design assumptions, process controls, inspection evidence, and buyer decisions so the recommendation can be verified on the actual resin, mold, machine, and production requirement.
What ISO 10993 does—and does not—mean
ISO 10993-1 is used within a biological evaluation and risk-management process; it is not a universal certificate that makes a resin or molded part safe for every device. The required endpoints depend on the nature, type, frequency, and duration of contact and the finished device context.
The FDA evaluates the final finished device, including processing and sterilization where applicable, rather than clearing an isolated material as a standalone medical device. Do not use ‘medical grade’ as a substitute for a device-specific assessment.
Define the use before selecting resin
Document direct or indirect contact, tissue or body fluid exposure, contact duration, patient population, intended use, sterilization method, temperature, chemicals, colorants, additives, fillers, adhesives, and manufacturing aids. The same polymer family can have different evidence and restrictions by grade and supplier.
Evidence and processing controls
Request the exact grade datasheet, regulatory or biocompatibility statements, formulation and change-notification policy, sterilization compatibility, extractables or chemical information where relevant, and lot traceability. Confirm that molding, cleaning, packaging, and sterilization do not introduce residuals or change the risk profile.
Supplier evidence supports the assessment; it does not replace final-device testing or the customer’s regulatory responsibility. Align the molding process, QMS, validation, and change control with the applicable market and device pathway.
A practical selection workflow
Classify contact and duration, identify relevant endpoints, screen grades, assess processing and sterilization, review supplier evidence, mold representative parts, evaluate the final finished configuration, and document the risk decision. Engage the responsible regulatory and biological-safety specialists for the product.
Frequently Asked Questions
Does ISO 10993 certify a plastic by itself?
No. ISO 10993 is used in a risk-based biological evaluation of a medical device and its final finished form. A material label alone is not a universal approval.
What information determines the relevant biocompatibility endpoints?
Contact nature and type, tissue, frequency and duration, material, processing, sterilization, additives, and the final device configuration are key inputs.
Can a molding supplier claim a part is medically safe?
Only within the evidence and responsibility agreed with the device manufacturer. Final-device evaluation and regulatory decisions belong to the applicable product owner and pathway.
What should be controlled during molding?
Exact resin grade and lot, drying, additives, regrind, cleaning, processing aids, tool cleanliness, packaging, sterilization compatibility, traceability, and change control.
Related Cavity Mold Services
Engineering and DFM; Mold making; Plastic injection molding; Contact Cavity Mold.
For a drawing, resin, tolerance, finish, cavity-count, or process-window review, contact Cavity Mold.